S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
The #1 Energy Stock to Buy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
The #1 Energy Stock to Buy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
The #1 Energy Stock to Buy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
S&P 500   3,852.36
DOW   32,920.46
QQQ   303.59
Mullen Automotive Stock, The Tide Has Turned
The #1 Energy Stock to Buy (Ad)
Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
What do Mastercard Earnings Indicate About Consumer Spending?
The #1 Energy Stock to Buy (Ad)
How to Find Penny Stocks to Invest and Trade
What Tyson Foods Q1 Means For Staples Stocks
The #1 Energy Stock to Buy (Ad)
ONSemi Is Marching Higher On Great Results
Can Cummins Power To A New High? 
NYSE:NVRO

Nevro - NVRO Stock Forecast, Price & News

$38.68
-1.11 (-2.79%)
(As of 02/6/2023 12:00 AM ET)
Add
Compare
Today's Range
$38.34
$39.63
50-Day Range
$35.60
$47.90
52-Week Range
$34.70
$78.90
Volume
389,847 shs
Average Volume
694,322 shs
Market Capitalization
$1.37 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00

Nevro MarketRank™ Forecast

Analyst Rating
Hold
1.93 Rating Score
Upside/​Downside
42.2% Upside
$55.00 Price Target
Short Interest
Bearish
9.00% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.31mentions of Nevro in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.72) to ($2.17) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.96 out of 5 stars

Medical Sector

591st out of 1,027 stocks

Surgical & Medical Instruments Industry

64th out of 105 stocks

NVRO stock logo

About Nevro (NYSE:NVRO) Stock

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.

Receive NVRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nevro and its competitors with MarketBeat's FREE daily newsletter.

NVRO Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
4 MedTech Stocks Set to Outpace Q3 Earnings Estimates
What 4 Analyst Ratings Have To Say About Nevro
See More Headlines
Receive NVRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nevro and its competitors with MarketBeat's FREE daily newsletter.

NVRO Company Calendar

Last Earnings
11/07/2021
Today
2/06/2023
Next Earnings (Confirmed)
2/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
945
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$55.00
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$31.00
Forecasted Upside/Downside
+42.2%
Consensus Rating
Hold
Rating Score (0-4)
1.93
Research Coverage
14 Analysts

Profitability

Net Income
$-131,360,000.00
Pretax Margin
-1.80%

Debt

Sales & Book Value

Annual Sales
$386.90 million
Book Value
$8.70 per share

Miscellaneous

Free Float
34,438,000
Market Cap
$1.37 billion
Optionable
Optionable
Beta
0.79

Key Executives

  • D. Keith GrossmanD. Keith Grossman
    Chairman, President & Chief Executive Officer
  • Roderick H. MacLeod
    Chief Financial Officer
  • David Caraway
    Chief Medical Officer
  • Christopher Christoforou
    Vice President-Technical Operations
  • Stephen Smith
    Vice President-Information Technology













NVRO Stock - Frequently Asked Questions

Should I buy or sell Nevro stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nevro in the last twelve months. There are currently 4 sell ratings, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" NVRO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NVRO, but not buy additional shares or sell existing shares.
View NVRO analyst ratings
or view top-rated stocks.

What is Nevro's stock price forecast for 2023?

14 analysts have issued 12-month price objectives for Nevro's stock. Their NVRO share price forecasts range from $31.00 to $95.00. On average, they predict the company's share price to reach $55.00 in the next twelve months. This suggests a possible upside of 42.2% from the stock's current price.
View analysts price targets for NVRO
or view top-rated stocks among Wall Street analysts.

How have NVRO shares performed in 2023?

Nevro's stock was trading at $39.60 at the beginning of 2023. Since then, NVRO shares have decreased by 2.3% and is now trading at $38.68.
View the best growth stocks for 2023 here
.

When is Nevro's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 16th 2023.
View our NVRO earnings forecast
.

How can I listen to Nevro's earnings call?

Nevro will be holding an earnings conference call on Thursday, February 16th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Nevro's earnings last quarter?

Nevro Corp. (NYSE:NVRO) issued its quarterly earnings results on Sunday, November, 7th. The medical equipment provider reported ($0.86) EPS for the quarter, beating the consensus estimate of ($0.87) by $0.01. The medical equipment provider earned $93.21 million during the quarter, compared to analyst estimates of $91.59 million. Nevro had a negative trailing twelve-month return on equity of 40.89% and a negative net margin of 2.01%. Nevro's revenue was down 14.1% on a year-over-year basis. During the same period in the prior year, the business posted ($0.29) earnings per share.

What guidance has Nevro issued on next quarter's earnings?

Nevro updated its FY 2022 earnings guidance on Monday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $406.40 million-$406.40 million, compared to the consensus revenue estimate of $405.14 million.

What is D. Keith Grossman's approval rating as Nevro's CEO?

9 employees have rated Nevro Chief Executive Officer D. Keith Grossman on Glassdoor.com. D. Keith Grossman has an approval rating of 68% among the company's employees.

What other stocks do shareholders of Nevro own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Nevro investors own include AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), General Electric (GE), Micron Technology (MU), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Adobe (ADBE) and Intuitive Surgical (ISRG).

What is Nevro's stock symbol?

Nevro trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVRO."

Who are Nevro's major shareholders?

Nevro's stock is owned by a variety of institutional and retail investors. Top institutional investors include Assenagon Asset Management S.A. (0.62%), Bank of Montreal Can (0.10%), Exchange Traded Concepts LLC (0.09%), Versor Investments LP (0.03%), Simplex Trading LLC (0.00%) and Zurcher Kantonalbank Zurich Cantonalbank (0.02%). Insiders that own company stock include D Keith Grossman, Elizabeth H Weatherman, Kashif Rashid, Kevin C Oboyle, Leslie Stretch, Michael F Demane, Michael F Demane, Niamh Louise Pellegrini and Shawn Mccormick.
View institutional ownership trends
.

How do I buy shares of Nevro?

Shares of NVRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Nevro's stock price today?

One share of NVRO stock can currently be purchased for approximately $38.68.

How much money does Nevro make?

Nevro (NYSE:NVRO) has a market capitalization of $1.37 billion and generates $386.90 million in revenue each year. The medical equipment provider earns $-131,360,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis.

How many employees does Nevro have?

The company employs 945 workers across the globe.

How can I contact Nevro?

Nevro's mailing address is 1800 BRIDGE PARKWAY, REDWOOD CITY CA, 94065. The official website for the company is www.nevro.com. The medical equipment provider can be reached via phone at (650) 251-0005 or via email at ir@nevro.com.

This page (NYSE:NVRO) was last updated on 2/7/2023 by MarketBeat.com Staff